A carregar...
Alemtuzumab in refractory Sézary syndrome
Sézary syndrome is a primary cutaneous T-cell lymphoma characterized by the triad of erythroderma, lymphadenopathy and circulating atypical cells. The emergence of new molecular targets has enabled the development of drugs such as alemtuzumab, an anti-CD52 monoclonal antibody, which has shown promis...
Na minha lista:
| Publicado no: | An Bras Dermatol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Sociedade Brasileira de Dermatologia
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5087225/ https://ncbi.nlm.nih.gov/pubmed/27828640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/abd1806-4841.20164322 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|